Medical and surgical treatment management in open angle glaucoma patients of Asian descent: A narrative review
- PMID: 40388924
- PMCID: PMC12352580
- DOI: 10.1177/11206721251340435
Medical and surgical treatment management in open angle glaucoma patients of Asian descent: A narrative review
Abstract
Glaucoma represents a progressive optic neuropathy characterized by optic nerve head damage, retinal nerve fiber layer thinning and visual field loss. There are significant disparities in the diagnosis, disease progression and treatment outcomes of glaucoma patients. Primary open angle glaucoma (OAG) patients of African descent have been found to have earlier and more severe disease than those of European descent. In 2020, half of the worldwide glaucoma patient population resided in Asia, where normal-tension and angle-closure glaucoma are more prevalent. The significant prevalence and diversity of OAG in Asia necessitates a better understanding of medical, laser, and surgical management in this growing population. PubMed and Embase database searches were conducted for all pertinent articles and abstracts published between January 1990 through January 2024 and review of the literature yielded 1,237 potential articles, from which 104 met the inclusion/exclusion criteria. The current literature suggests that prostaglandin analogues are efficacious and safe in OAG Asian patients, however little is known on other classes of hypotensive drugs. Published data on the laser and surgical management of glaucoma in Asian populations describe differences in outcomes between Asian and Caucasian populations including from minimally invasive glaucoma surgery. Longitudinal studies specifically designed to investigate treatment impact while accounting for access to care in the increasing global aging Asian population are warranted.
Keywords: GLAUCOMA; glaucoma incisional surgery; glaucoma medical therapies; laser surgery; tube shunts.
Conflict of interest statement
Declaration of conflicting interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Financial Disclosures
Professor Alon Harris would like to disclose that he received remuneration from AdOM, Qlaris, and Cipla for serving as a consultant, and he serves on the board of AdOM, Qlaris and SlitLed. Professor Alon Harris holds an ownership interest in AdOM, Oxymap, Qlaris, SlitLed, and AEYE Health. Alice Verticchio Vercellin is an external collaborator of the IRCCS Fondazione Bietti, Rome. If you have questions regarding paid relationships that your physician/researcher may have with industry, you are encouraged to talk with your physician/researcher, or check for industry relationships posted on individual faculty pages on our website at
Figures

Similar articles
-
Medical versus surgical interventions for open angle glaucoma.Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD004399. doi: 10.1002/14651858.CD004399.pub3. Cochrane Database Syst Rev. 2012. PMID: 22972069 Free PMC article.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Laser trabeculoplasty for open-angle glaucoma and ocular hypertension.Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD003919. doi: 10.1002/14651858.CD003919.pub3. Cochrane Database Syst Rev. 2022. PMID: 35943114 Free PMC article.
-
Neuroprotection for treatment of glaucoma in adults.Cochrane Database Syst Rev. 2013 Feb 28;2(2):CD006539. doi: 10.1002/14651858.CD006539.pub3. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2017 Jan 25;1:CD006539. doi: 10.1002/14651858.CD006539.pub4. PMID: 23450569 Free PMC article. Updated.
-
Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.Cochrane Database Syst Rev. 2022 Jun 10;6(6):CD013817. doi: 10.1002/14651858.CD013817.pub2. Cochrane Database Syst Rev. 2022. PMID: 35686679 Free PMC article.
References
-
- Agrawal A, Singh A and Mittal SK. Glaucoma in Asia- an epidemiological perspective. Nepal J Ophthalmol 2017; 9: 208–211. - PubMed
-
- Wang N, Wu H and Fan Z. Primary angle closure glaucoma in Chinese and Western populations. Chin Med J (Engl) 2002; 115: 1706–1715. - PubMed
-
- Amerasinghe N and Aung T. Angle-closure: risk factors, diagnosis and treatment. Prog Brain Res 2008; 173: 31–45. - PubMed
-
- Anwar F and Turalba A. An overview of treatment methods for primary angle closure. Semin Ophthalmol 2017; 32: 82–85. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous